Edmonton-based NiaHealth has raised $5.75 million in seed funding to expand its Longevity-as-a-Service platform, bringing total investment to $8.25 million. Led by Golden Ventures, the round includes prominent backers from Fullscript, Good Future, Roar Ventures, and Version One. Since emerging from stealth, NiaHealth has tested over 100,000 biomarkers and grown users by 30% monthly.
The startup aims to deliver proactive, personalized healthcare through clinical testing, AI-driven insights, and clinician support. Upcoming Platform 2.0 upgrades include wearables integration, CGM, and expanded biomarker analysis. CEO Sameer Dhar says the goal is to transform Canada’s care model from reactive to preventative.
Want to know more? Check out the source code on Calgary.tech.